Dilution is a real possibility if script growth can't off set the cost of reduce it.... i'm long 60k shares and take 4gm of Vascepa daily for its inflamm qualities
the anecdotal evidence in favor of EPA in a variety of cases is overwhelming... i wish i had more power in the media/government to get the story told. I take 4 gms of Vascepa a day for its anti inflam qualities. My lipids are excellent so for me it is like a vitamin on steroids :)
Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer
Cancer Prevention Research, 09/12/2014 Clinical Article
Vasudevan A, et al. – The primary objectives of this investigation are to examine whether eicosapentaenoic acid synergizes with FuOx, the backbone of colon cancer chemotherapy, and (b) whether EPA by itself or in combination with conventional chemotherapy prevents the recurrence of colon cancer via eliminating/suppressing CSCs/CSLCs. The data suggest that EPA by itself or in combination with FuOx could be an effective preventive strategy for recurring CRC.
Doc Schwartz still has a problem with the proximal colon. One question for the good Doc ... for whatever reason colonoscopy is not an option for your wife- what screening test do you suggest she gets? If Doc Schwartz say FIT, he needs to learn more about interval CRC, proximal CRC and HGD. He wouldn't recommend FIT; he is too smart and sometimes being too smart can do a lot of damage to those who trust these types without doing your own DD.. i'm not talking about $ here i'm talking about saving lives with a clearly superior screening tool.
As if these folks need more health concerns.... hopefully CG may be of some help.
Early colon screening of adult patients with cystic fibrosis reveals high incidence of adenomatous colon polyps
Journal of Clinical Gastroenterology, 09/11/2014 Clinical Article
Billings JL, et al. – The primary aim of this study was to estimate the incidence of adenomatous colon polyps in patients with cystic fibrosis (CF) during systematic screening by colonoscopy. CF has features of a hereditary colon cancer syndrome. Increasing life expectancy of CF patients suggests that earlier colon screening in this population may be warranted. Optimal criteria for initiation of screening and frequency of surveillance should be subject of further studies.
i sold and took the tax loss against some other gains ... bought more overall shares a couple of months ago... i take vascepa and so should millions due to its aa/epa qualities .... but sometimes the science doesn't get rewarded... people will die because of what the fda did in october...scary
as long as none of us has proximal crc.... everyone is still welcome to use FIT- i'm not a doc but all my loved ones will be screened with CG
KC discussed cost effectiveness as compared to breast cancer screening and cervical cancer screening. The particular study he mentioned said it compared quite favorably at many price points and time intervals.
purchased shares in this company in 07' and sold in 08' to buy exas ... today isrg has a market cap of 17B on 2B of revs. A EBITDA of 731.8 Mil .... both disruptive technologies can't help but ponder where exas will be in 5 years. One could have purchased ISRG for 15 bucks in '03; today it closed at $473... the best is yet come longs :)
Cat, therein lies another obstacle as I recall KC stating that the AA community was less likely relatively speaking to take part in the deep-c study. Hence the lower absolute numbers. The fact AA's suffer more proximal colon crc's than the other pop. subsets makes the FIT, my earlier point, less suitable. I agree more needs to be done in making CG more sensitive in this pop.
Cat, 62% of what ? Proximal CRC? HGD? or CRC in general... thanks ...btw the over all frequencies of MSI, BRAF, and KRAS mutations were not different by location of colon in this study. I appreciate your contributions to the board of late ;)
These excerpts were from an article published in MDlinx yesterday. My takeaway is FIT is not in the best interest in AAs due to the relative increased rate of proximal crc in their population.
Purpose: AAs have the highest incidence of CRC with other US populations and more proximal CRC's
Design: 566 AA and 328 NHW CRCs were ascertained in five chicago hospitals
Results: Over a 10 year period, the median age at diagnosis significantly decreased for both AAs non hispanic whites. AA's had more proximal CRC than NHWs......
Conclusions: Patients with CRC have gotten progressively younger. The excess of crc in AAs predominantly consists of more proximal, microsatellite stable tumors.....
I'm also a Vascepa user- 4gms daily ... great lipid panel but my buddy is a cardiovascular surgeon.. studied with ballantyne and put his family and friends on Vascepa because it's good for us :) he is a big fan of EPA/AA ... the best is yet to come. I have health net and pay 40 bucks a month
steph, the problem FIT is always going to have is on the proximal colon. Once the PCP's are educated on this we should be the clear choice provided there are no out of pocket costs.
and the hospitalizations following colonoscopy ... not a huge number statistically however my neighbor passed as a result of an endoscopic procedure on his colon -very rare but it happens as the paper work you sign clearly points out ....